mizoribine has been researched along with Libman-Sacks Disease in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.88) | 18.7374 |
| 1990's | 3 (17.65) | 18.2507 |
| 2000's | 6 (35.29) | 29.6817 |
| 2010's | 7 (41.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amano, K; Chino, K; Ito, T; Kato, H; Kondo, T; Kurasawa, T; Nagasawa, H; Nishi, E; Nishimura, K; Ogawa, H; Okuyama, A; Sakai, R; Shibata, A; Takei, H | 1 |
| Ando, T; Hattori, S; Honda, M; Ikeda, M; Sasaki, S; Tanaka, Y; Yoshikawa, N | 1 |
| Akazawa, S; Aramaki, T; Arima, K; Eguchi, K; Fujikawa, K; Ichinose, K; Ida, H; Iwamoto, N; Kamachi, M; Kawakami, A; Kawashiri, SY; Nakamura, H; Origuchi, T; Tamai, M | 1 |
| Katayama, A; Makino, H; Matsumoto, Y; Nasu, Y; Otsuka, F; Tanabe, K; Tsukamoto, N; Yamanaka, R | 1 |
| Aizawa-Yashiro, T; Ito, E; Oki, E; Tanaka, H; Tsuruga, K; Watanabe, S | 1 |
| Hara, T; Hiromasa, T; Kagawa, H; Makino, H; Sada, KE; Takaki, A; Yamanaka, R | 1 |
| Kishimoto, M; Nomura, A; Ohara, Y; Okada, M; Rokutanda, R; Shimizu, H; Suyama, Y; Yamaguchi, K | 1 |
| Onda, H; Watanabe, T | 1 |
| Imanaka, H; Kawano, Y; Maeno, N; Ohkawa, T; Takei, S; Yoshidome, K | 1 |
| Fujita, T; Iijima, K; Kamioka, I; Matsuo, M; Nakanishi, K; Nozu, K; Tanaka, R; Yoshikawa, N; Yoshiya, K | 1 |
| Ito, E; Oki, E; Suzuki, K; Tanaka, H; Tsugawa, K | 1 |
| Kamata, K; Kobayashi, Y; Masaki, Y; Okubo, M; Tanaka, T; Uchiyama, T | 1 |
| Aizawa, K; Hamano, T; Iwasaki, T; Kakishita, E; Kobayashi, K | 1 |
| Aihara, Y; Ibe, M; Kuriyama, T; Mitsuda, T; Mori, M; Shimizu, C; Takahashi, Y; Yokota, S | 1 |
| Kaizuka, M; Okumura, K; Osawa, H; Shirato, KI; Tamura, N; Tsunoda, S; Yamabe, H | 1 |
| Katoh, K; Koizumi, S; Okada, Y; Ushida, H | 1 |
| Aihara, Y; Ibe, M; Imagawa, T; Ito, S; Kobayashi, S; Mitsuda, T; Miyamae, T; Mori, M; Yokota, S | 1 |
3 trial(s) available for mizoribine and Libman-Sacks Disease
| Article | Year |
|---|---|
Combination therapy with steroids and mizoribine in juvenile SLE: a randomized controlled trial.
Topics: Administration, Oral; Adolescent; Adrenal Cortex Hormones; Age of Onset; Child; Disease-Free Survival; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Japan; Kaplan-Meier Estimate; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Methylprednisolone; Prednisolone; Proteinuria; Pulse Therapy, Drug; Recurrence; Ribonucleosides; Time Factors; Treatment Outcome | 2010 |
Efficacy of mizoribine in the treatment of systemic lupus erythematosus in children.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Antinuclear; Blood Sedimentation; Child; Complement C3; Complement C4; Female; Follow-Up Studies; Humans; Lupus Erythematosus, Systemic; Proteinuria; Ribonucleosides; Time Factors; Treatment Outcome | 2004 |
Mizoribine intermittent pulse protocol for induction therapy for systemic lupus erythematosus in children: an open-label pilot study with five newly diagnosed patients.
Topics: Adolescent; Biopsy; Child; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Kidney; Lupus Erythematosus, Systemic; Male; Prednisolone; Pulse Therapy, Drug; Ribonucleosides; Severity of Illness Index; Treatment Outcome | 2008 |
14 other study(ies) available for mizoribine and Libman-Sacks Disease
| Article | Year |
|---|---|
Successful treatment of class IV+V lupus nephritis with combination therapy of high-dose corticosteroids, tacrolimus and intravenous cyclophosphamide.
Topics: Adolescent; Antihypertensive Agents; Biphenyl Compounds; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Female; Humans; Hypertension, Renal; Immunosuppressive Agents; Infusions, Intravenous; Irbesartan; Lupus Erythematosus, Systemic; Lupus Nephritis; Nephrotic Syndrome; Prednisolone; Pulse Therapy, Drug; Recurrence; Ribonucleosides; Severity of Illness Index; Tacrolimus; Tetrazoles | 2013 |
Successful treatment of chronic lupus myocarditis with prednisolone and mizoribine.
Topics: Adult; Female; Glucocorticoids; Heart Failure; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Myocarditis; Prednisolone; Ribonucleosides; Treatment Outcome | 2010 |
Unexpected occurrence of adrenal Cushing's syndrome in a patient with systemic lupus erythematosus.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Angiomyolipoma; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Cushing Syndrome; Drug Therapy, Combination; Female; Humans; Hypertension; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Nifedipine; Prednisolone; Ribonucleosides; Spironolactone; Tetrazoles | 2011 |
Addition of mizoribine to the prednisolone plus tacrolimus treatment regimen in a patient with lupus flare.
Topics: Child; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Prednisolone; Ribonucleosides; Tacrolimus; Treatment Outcome | 2012 |
Mizoribine, tacrolimus, and corticosteroid combination therapy successfully induces remission in patients with lupus nephritis.
Topics: Adrenal Cortex Hormones; Adult; Aged; Creatinine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lupus Nephritis; Methylprednisolone; Middle Aged; Pilot Projects; Prednisolone; Proteinuria; Remission Induction; Retrospective Studies; Ribonucleosides; Tacrolimus; Treatment Outcome | 2012 |
Efficacy and safety of multitarget therapy with mizoribine and tacrolimus for systemic lupus erythematosus with or without active nephritis.
Topics: Adult; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Middle Aged; Remission Induction; Retrospective Studies; Ribonucleosides; Tacrolimus; Time Factors; Treatment Outcome | 2012 |
Hemichorea with antiphospholipid antibodies in a patient with lupus nephritis.
Topics: Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Brain; Child; Chorea; Functional Laterality; Humans; Immunosuppressive Agents; Infarction, Middle Cerebral Artery; Lupus Erythematosus, Systemic; Lupus Nephritis; Magnetic Resonance Imaging; Male; Ribonucleosides; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2004 |
High-dose mizoribine treatment for adolescents with systemic lupus erythematosus.
Topics: Adolescent; Child; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Ribonucleosides; Uric Acid | 2006 |
Effect of mizoribine on lupus nephropathy of New Zealand black/white F1 hybrid mice.
Topics: Animals; Body Weight; Glomerulonephritis; Kidney; Kidney Function Tests; Life Expectancy; Lupus Erythematosus, Systemic; Mice; Mice, Inbred NZB; Organ Size; Ribonucleosides; Spleen | 1984 |
[A case of systemic lupus erythematosus (SLE) successfully treated with mizoribine (Bredinin)].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Middle Aged; Ribonucleosides | 1994 |
[Effects of combined administration of prednisolone and mizoribine in the course of remission for SLE children with nephritis].
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Drug Therapy, Combination; Female; Humans; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Prednisolone; Remission Induction; Ribonucleosides | 1994 |
Systemic lupus erythematosus associated with transverse myelitis and parkinsonian symptoms.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antiparkinson Agents; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Levodopa; Lupus Erythematosus, Systemic; Myelitis; Parkinson Disease, Secondary; Ribonucleosides | 1997 |
[Systemic lupus erythematosus presenting as a brainstem infarction and hemorrhage during treating retroperitoneal abscess: a case report].
Topics: Adult; Anti-Inflammatory Agents; Brain Stem Infarctions; Cerebral Hemorrhage; Drainage; Female; Humans; Lupus Erythematosus, Systemic; Prednisolone; Retropharyngeal Abscess; Ribonucleosides | 2001 |
Mizoribine as an effective combined maintenance therapy with prednisolone in child-onset systemic lupus erythematosus.
Topics: Adolescent; Anti-Inflammatory Agents; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Plasmapheresis; Prednisolone; Recurrence; Ribonucleosides | 2002 |